Medical treatment of glomerular diseases.
D000328:Adult; D019867:Anti-Glomerular Basement Membrane Disease / Q000188:drug therapy; D001379:Azathioprine / Q000627:therapeutic use; D002648:Child; D002699:Chlorambucil / Q000627:therapeutic use; D003520:Cyclophosphamide / Q000627:therapeutic use; D004176:Dipyridamole / Q000627:therapeutic use; D005921:Glomerulonephritis / Q000145:classification / Q000188:drug therapy* / Q000209:etiology / Q000276:immunology; D005923:Glomerulosclerosis, Focal Segmental / Q000188:drug therapy; D006801:Humans; D007105:Immune Complex Diseases / Q000188:drug therapy*; D007070:Immunoglobulin A / Q000378:metabolism; D007213:Indomethacin / Q000627:therapeutic use; D007678:Kidney Glomerulus / Q000276:immunology; D011241:Prednisone / Q000627:therapeutic use; D014859:Warfarin / Q000627:therapeutic use
D007070:Immunoglobulin A; D002699:Chlorambucil; D014859:Warfarin; D004176:Dipyridamole; D003520:Cyclophosphamide; D001379:Azathioprine; D011241:Prednisone; D007213:Indomethacin